2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Quantitative assessment of DBS-induced gait disorder in patients with essential tremor

D. Kroneberg, T. Schmitz-Hübsch, A. Gropp, G.H. Schneider, A.A. Kühn (Berlin, Germany)
Quantitative measurements of deficit type and severity in focal embouchure dystonia

A.E. Morris, S.D. Anderson, J.W. Mink (Rochester, NY, USA)
Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy

Y. Lee, D.K. Lee, J.M. Lee, S.J. Chung, J.J. Lee, Y.H. Sohn, P.H. Lee (Seoul, Korea)
Randomised trial comparing dopamine agonist, MAOB inhibitor and COMT inhibitor as adjuvant therapy in later Parkinson’s disease (PD)

C.E. Clarke, S. Patel, N. Ives, C. Rick, A. Gray, C. Jenkinson, E. McIntosh, K. Wheatley, A. Williams, R. Gray (Birmingham, United Kingdom)
Randomized controlled trial protocol: Balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

T.T.C. Capato, J. Tornai, V.F. Gianguiagi, R.R. Firmino, E.R. Barbosa, M.E. Piemonte (São Paulo, Brazil)
Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease

J.R. Zhang, J. Chen, Z.J. Yang, H.J. Zhang, Y.T. Fu, Y. Shen, P.C. He, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)
Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial

W. Schrempf, M. Fauser, K. Otto, M. Wienecke, C. Ossig, S. Brown, A. Maass, M.D. Brandt, U. Schwanebeck, X. Graehlert, H. Reichmann, A. Storch (Dresden, Germany)
RBD increase non-motor symptom in Parkinson’s disease

Y. Wu, Y. Liu, X. Zhu, X. Zhang, S. Kuo, W.G. Ondo (Shanghai, People's Republic of China)
RE-024: A potential phosphopantothenate replacement therapy in 2 patients with pantothenate kinase-associated neurodegeneration (PKAN)

P. Roa, P. Stoeter, E. Perez, M. Santana (Santo Domingo, Dominican Republic)
RE-024: Mechanism of action and efficacy in non-clinical models

M. Beconi, E. Monteagudo, A. Di Marco, S. Malancona, D. Elbaum, S. Harper (San Diego, CA, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z